相关实验视频

Updated: Jun 16, 2025

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model

Published on: January 13, 2023

伊弗梅克与调节的电热过热协同作用,并在三阴性乳腺癌小鼠模型中改善其抗癌作用

Kenan Aloss^1,2, Pedro Henrique Leroy Viana¹, Syeda Mahak Zahra Bokhari¹

¹Institute of Translational Medicine, Semmelweis University, Üllői út 26., Budapest 1085, Hungary.

ACS pharmacology & translational science

|August 15, 2024

概括

这项研究表明,将调节电热高温 (mEHT) 与ivermectin (IVM) 结合起来,可以通过抑制癌细胞生长和促进细胞死亡来有效治疗三阴性乳腺癌 (TNBC).

科学领域:

在瘤学瘤学.
癌症治疗癌症治疗
药理学药理学是指药理学的学科.

背景情况:

三阴性乳腺癌 (TNBC) 是一种具有有限治疗选择的侵袭性亚型.
调节电热高温 (mEHT) 显示出作为辅助疗法的前景,但可以调节HSPB1,一种促癌分子.
伊弗梅克丁 (IVM) 是一种具有潜在抗癌性能的杀虫剂药物.

研究的目的:

调查ivermectin (IVM) 和调节电热 (mEHT) 在治疗三阴性乳腺癌 (TNBC) 的协同作用.
确定IVM是否可以抑制mEHT诱导的HSPB1酸化,从而增强抗癌效应.
在临床前TNBC模型中评估组合治疗的安全性和有效性.

主要方法:

在小鼠模型 (BALB/c) 中使用同源4T1 TNBC细胞.
小鼠接受了mEHT,IVM或两种疗法的组合治疗.
评估了瘤生长,HSPB1酸化,亡,增殖和体重.

主要成果:

结合mEHT和IVM证明了协同作用的瘤生长抑制.
IVM有效降低了mEHT诱导的HSPB1酸化的调节.
结合疗法导致了显著的癌症组织损伤,增加了亡,并减少了扩散.
mEHT + IVM组合被很好地容忍,没有观察到显著的体重减轻.

结论:

调节电热高温 (mEHT) 和ivermectin (IVM) 的组合代表了三阴性乳腺癌 (TNBC) 的新且有效的治疗策略.
这种组合通过抑制HSPB1酸化和诱导瘤细胞死亡来增强抗癌效应.
mEHT + IVM疗法是TNBC治疗的安全和有前途的选择.

更多相关视频

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.